...
首页> 外文期刊>癌と化学療法 >Postoperative adjuvant chemotherapy for non-small cell lung cancer
【24h】

Postoperative adjuvant chemotherapy for non-small cell lung cancer

机译:非小细胞肺癌术后辅助化疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Patients with completely resected non-small-cell lung cancer (NSCLC) are subjects for postoperative adjuvant treatment. Recently, several randomized trials with a large number of enrolled patients have shown that platinum-based chemotherapy has potential for improving survival among patients with completely resected NSCLC in Western countries. In Japan, uracil-tegafur was also shown to improve survival among patients with completely resected stage I adenocarcinoma. This review evaluated the role of adjuvant chemotherapy, based on the results of randomized trials and meta-analyses.
机译:患有完全切除的非小细胞肺癌(NSCLC)的患者接受术后辅助治疗。最近,针对大量入组患者的几项随机试验表明,在西方国家,铂类化学疗法具有改善完全切除的NSCLC患者生存率的潜力。在日本,还显示了尿嘧啶-替加氟可改善完全切除的I期腺癌患者的生存率。这篇综述基于随机试验和荟萃分析的结果评估了辅助化疗的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号